A synthetic nasal formulation of the hormone oxytocin reduced caloric intake in healthy men, particularly consumption of fatty foods, after a single treatment, a new study finds. The results, to be presented Sunday at The ...
Mar 5, 2015
0
19
(Medical Xpress)—A pair of researchers with Emory University in Atlanta has published a Perspective piece in the journal Science, questioning whether oxytocin can help people with an autism spectrum disorder (ASD). In their ...
Researchers are developing a novel prochlorperazine nasal spray formulation as a potential new treatment for migraines. This work is being presented at the 2014 American Association of Pharmaceutical Scientists (AAPS) Annual ...
Nov 6, 2014
0
0
"Every year, drug overdoses are responsible for roughly 1000 ambulance calls in Oslo," says Arne Skulberg, an anaesthesiologist, a PhD candidate at NTNU and the 2014 winner of Norway's Researcher Grand Prix competition.
Oct 28, 2014
0
0
With Americans on edge about the potential spread of Ebola, it is easy to overlook another virus to which we have long been accustomed – influenza. According to estimates by the Centers for Disease Control and Prevention ...
Oct 27, 2014
0
0
The only drug currently approved for treatment of stroke's crippling effects shows promise, when administered as a nasal spray, to help heal similar damage in less severe forms of traumatic brain injury.
Oct 7, 2014
0
0
(HealthDay)—Pediatricians are urging that all children aged 6 months and older be vaccinated for the upcoming flu season.
Sep 22, 2014
1
0
A new, lifesaving product aimed at reducing the death toll from heroin abuse—developed by a professor at the University of Kentucky College of Pharmacy—is in its final round of clinical trials and has received Fast Track ...
Aug 7, 2014
0
0
A group of scientists led by researchers from the California Academy of Sciences and Trinity College Dublin have taken a promising step towards the development of a universal antidote for snakebite. Their research may lead ...
Jun 10, 2014
0
0
A team of researchers, led by Dr. Matthew Lewin of the California Academy of Sciences and Dr. Stephen P. Samuel of Trinity College Dublin, Ireland has taken another promising step toward developing a universal antidote for ...
May 28, 2014
0
0
